Refaat Shehab¹* and MO Ababneh²

¹Senior Consultant, Anaesthesiologist, Abdali Medical Centre, Al-Istethmar Street - Abdali Boulevard - Amman, Jordan
²Consultant, Clinical Director, Anaesthesia Department, Abdali Medical Centre, Al-Istethmar Street - Abdali Boulevard - Amman, Jordan

*Corresponding Author: Refaat Shehab, Senior Consultant, Anaesthesiologist, Abdali Medical Centre, Al-Istethmar Street - Abdali Boulevard - Amman, Jordan.

Received: August 27, 2021; Published:

Abstract

Mitochondrial encephalopathy, lactic acidosis, stroke-like symptoms (MELAS) syndrome is a specific mitochondrial myopathy that results in defects in respiratory enzyme complexes I and IV.

This ultimately causes defects in aerobic metabolism, especially in high-energy-requiring organs, leading to an obvious concern with anesthetic management.

Mitochondrial disease (MD) is recognized as an important cause of a wide range of physiologic changes that affect the perioperative period [1], strongly affected by anesthetics.

We managed a 36-year male patient with MELAS, underwent a ureteroscopy, lithotripsy and indwelling double J stent exchange. The patient was successfully managed with a spinal/epidural anaesthesia.

Keywords: MELAS; Anesthetic Management; Myopathy; Genetics

References

1. Muravchick S and Levy RJ. “Clinical implications of mitochondrial dysfunction”. Anesthesiology 4 (2006): 819-837.
2. Falk MJ and Sondheimer N. “Mitochondrial genetic diseases”. Current Opinion in Pediatrics 6 (2010): 711-716.
3. Finsterer J. “Central nervous system manifestations of mitochondrial disorders”. Acta Neurologica Scandinavica 4 (2006): 217-238.
4. Codier E and Codier D. “Understanding mitochondrial disease and goals for its treatment”. The British Journal of Nursing 5 (2014): 254-260.
5. Online Mendelian Inheritance in Man (2015).
6. Petty RKH., et al. “The clinical features of mitochondrial myopathy”. Brain 109 (1986): 915-938.
7. Wallace JJ., et al. “Anaesthesia and mitochondrial disease”. Paediatric Anesthesia 8 (1998): 249-254.
8. Malignant Hyperthermia Association of the United States. Does mitochondrial myopathy (MM) increase an individual’s susceptibility to malignant hyperthermia (MH)? Malignant Hyperthermia Association of the United States website (2015).
9. RJ Dandurand., et al. “Mitochondrial disease. Pulmonary function, exercise performance, and blood lactate levels”. Chest 1 (1995): 182-189.
10. D'Ambra MN., et al. “Kearns-Sayer syndrome and pancuronium-succinylcholine-induced neuromuscular blockade”. Anesthesiology 51 (1979): 343-345.
11. Rosaeg OP., et al. “Anaesthesia management of labour and delivery in parturient with mitochondrial myopathy”. Canadian Journal of Anesthesia 43 (1996): 403-407.

Citation

Citation: Refaat Shehab and MO Ababneh. “Anesthetic Management of a Patient with Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-Like Symptoms (MELAS): A Case Report”. Acta Scientific Cancer Biology 5.10 (2021): 04-07.

Copyright

Copyright: © 2021 Refaat Shehab and MO Ababneh. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.